Schedule 13G ownership disclosure
Ampio Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 03209T109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,298,664
- Percent of class
- 5.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-17-002147
- Form type
- SC 13G
- Filer
- Ampio Pharmaceuticals, Inc.
- CIK
- CIK 1411906
- Filed
- Jan 30, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership